India Hotspot For Emerging Infectious Diseases, Says Report

A study carried out by international group of researchers called, India a hotspot for emerging infectious diseases (EIDs) like HIV/AIDS and SARS.

The study findings were released in the journal ‘Nature.’

In medical terms, the word 'emerging diseases' is described as newly identified pathogens, or old ones traveling to novel areas.

The scientists said that the diseases, which travel from animals to humans (zoonoses) like bird flu, are of special worry, and they have grown throughout the world.

Researchers from the Zoological Society of London (ZSL), the US-based University of Georgia and Columbia University's Earth Institute examined 335 incidents of earlier disease emergence, starting from 1940, and found that zoonoses are the existing and crucial danger in causing new illnesses to come out.

And the majority of the cases, comprising SARS and the Ebola virus, developed in mammals.

Kate E. Jones, a biodiversity scientist at the Zoological Society of London and first author of the international study said, “India risks new epidemics as the human population expands into natural wilderness, coming into contact with a diverse range of wildlife that harbour unusual diseases.”

Kate stated that it’s really important to thwart further interruption into areas of high biodiversity.

Other zooneses in India comprise occurrences of Japanese encephalitis in UP, the Surat plague, leptospirosis and more usual infections including rabies and anthrax.

The analysis also discovered that disease issues have roughly increased four times over the last 50 years throughout the world.

In addition, more diseases emerged during the 1980s than any other decade. According to the report, insect-transmitted maladies saw a peak during 1990s.

The researchers also prepared a detailed map showing up the world’s hotspots for emerging infectious diseases (EIDs). In addition to India, China and sub-Saharan Africa are the domains where there is growing chances of EIDs.

According to the researchers, around 20% of known emergences are multi-drug-resistant strains of previously known pathogens like tuberculosis.